Showing 2 posts of 2 posts found.
Celgene has had a rough six months, its share price since the beginning of October has dropped from $146 to …
Celgene president and chief operating officer Mike Alles has been promoted to the top job after an executive restructure at …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO